Importantly, phospho-tau immunoreactivity exhibited a somatodendritic distribution, thus resembling the typical ‘pretangle’ lesion observed in the brain of nondemented old individuals and of patients affected by late-onset AD (Bancher et al., 1989). The gene discussed is MAPT; the disease is Alzheimer disease.